EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
Latest Information Update: 28 May 2024
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hyperlipidaemia; Lipid metabolism disorders
- Focus Therapeutic Use
- Acronyms EMERALD
Most Recent Events
- 23 May 2024 According to EISAI media release, announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical Oncology Annual Meeting which is taking place virtually and inperson in Chicago, Illinois from May 31 to June 4.
- 02 Aug 2023 Status changed from active, no longer recruiting to completed.
- 30 Jun 2023 Status changed from recruiting to active, no longer recruiting.